- 1.
Stockley’s drug interactions. 2012. [Last accessed: 15 March 2012]. (Guideline Ref ID STOCKLEY2012)
- 2.
The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. 2012. [Last accessed: 1 March 2012]. (Guideline Ref ID NICE2012)
- 3.
Abram HS, Buckloh LM, Schilling LM, Wiltrout SA, Ramirez-Garnica G, Turk WR. A randomized, controlled trial of a neurological and psychoeducational group appointment model for pediatric headaches. Children’s Health Care. 2007;36(3):249–265. (Guideline Ref ID ABRAM2007)
- 4.
Adelman JU, Adelman LC, Von SR. Cost-effectiveness of antiepileptic drugs in migraine prophylaxis.
Headache. 2002;42(10):978–983. (Guideline Ref ID ADELMAN2002) [
PubMed: 12453029]
- 5.
Adelman JU, Von Seggern RL, Mannix LK. Migraine headaches: Implications for management from a nationwide patient survey. Headache Quarterly. 2000;11(2):105–112. (Guideline Ref ID ADELMAN2000)
- 6.
Afshari D, Rafizadeh S, Rezaei M. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
International Journal of Neuroscience. 2012;122(2):60–68. (Guideline Ref ID AFSHARI2012) [
PubMed: 21950578]
- 7.
Akpek S, Arac M, Atilla S, Onal B, Yucel C, Isik S. Cost-effectiveness of computed tomography in the evaluation of patients with headache.
Headache. 1995;35(4):228–230. (Guideline Ref ID AKPEK1995) [
PubMed: 7775181]
- 8.
Antunes NL, De Angelis LM. Neurologic consultations in children with systemic cancer.
Pediatric Neurology. 1999;20(2):121–124. (Guideline Ref ID ANTUNES1999) [
PubMed: 10082340]
- 9.
Apostol G, Cady RK, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, et al. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
Headache. 2008;48(7):1012–1025. (Guideline Ref ID APOSTOL2008) [
PubMed: 18705027]
- 10.
Association for Palliative Medicine of Great Britain and Ireland, British Pain Society.
The use of drugs beyond licence in palliative care and pain management. 2005. [Last accessed: 14 June 2012]. Available from:
http://www.britishpainsociety.org/book_usingdrugs_main.pdf.
(Guideline Ref ID BPS2005)- 11.
Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ. Oral zolmitriptan is effective in the acute treatment of cluster headache.
Neurology. 2000;54(9):1832–1839. (Guideline Ref ID BAHRA2000) [
PubMed: 10802793]
- 12.
Baker HL Jr. Cranial CT in the investigation of headache: cost-effectiveness for brain tumors.
Journal of Neuroradiology. 1983;10(2):112–116. (Guideline Ref ID BAKER1983) [
PubMed: 6410008]
- 13.
Baos V, Ester F, Castellanos A, Nocea G, Caloto MT, Gerth WC, et al. Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes.
International Journal of Clinical Practice. 2005;59(3):281–286. (Guideline Ref ID BAOS2005) [
PubMed: 15857323]
- 14.
Belam J, Harris G, Kernick D, Kline F, Lindley K, McWatt J, et al. A qualitative study of migraine involving patient researchers.
British Journal of General Practice. 2005;55(511):87–93. (Guideline Ref ID BELAM2005) [
PMC free article: PMC1463213] [
PubMed: 15720928]
- 15.
Bell R, Montoya D, Shuaib A, Lee MA. A comparative trial of three agents in the treatment of acute migraine headache.
Annals of Emergency Medicine. 1990;19(10):1079–1082. (Guideline Ref ID BELL1990) [
PubMed: 2221511]
- 16.
Bennett MH, French C, Schnabel A, Wasiak J, Kranke P. Normobaric and hyperbaric oxygen therapy for migraine and cluster headache.
Cochrane Database of Systematic Reviews. 2008;(3):CD005219. (Guideline Ref ID BENNETT2008) [
PubMed: 18646121]
- 17.
Bove G, Nilsson N. Spinal manipulation in the treatment of episodic tension-type headache: a randomized controlled trial.
Journal of the American Medical Association. 1998;280(18):1576–1579. (Guideline Ref ID BOVE1998) [
PubMed: 9820258]
- 18.
Brandes J, Poole A, Kallela M, Schreiber C, MacGregor E, Silberstein S, et al. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
Cephalalgia. 2009;29(11):1133–1148. (Guideline Ref ID BRANDES2009) [
PubMed: 19811503]
- 19.
Brandes JL, Kudrow D, Stark SR, O’Carroll CP, Adelman JU, O’Donnell FJ, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
Journal of the American Medical Association. 2007;297(13):1443–1454. (Guideline Ref ID BRANDES2007A) [
PubMed: 17405970]
- 20.
Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate for Migraine Prevention: A Randomized Controlled Trial.
Journal of the American Medical Association. 2004;291(8):965–973. (Guideline Ref ID BRANDES2004) [
PubMed: 14982912]
- 21.
Brighina F, Salemi G, Fierro B, Gasparro A, Balletta A, Aloisio A, et al. A validation study of an Italian version of the “ID Migraine”
Headache. 2007;47(6):905–908. (Guideline Ref ID BRIGHINA2007) [
PubMed: 17578542]
- 22.
British Association for the Study of Headache (BASH). Guidelines for all healthcare professionals in the diagnosis and management of cluster type migraine, tension type, cluster and medication over-use headache. 2007. [Last accessed: 25 March 2010]. (Guideline Ref ID BASH2007)
- 23.
Bronfort G, Nilsson N, Haas M, Evans R, Goldsmith CH, Assendelft WJ, et al. Non-invasive physical treatments for chronic/recurrent headache.
Cochrane Database of Systematic Reviews. 2004;(3):CD001878. (Guideline Ref ID BRONFORT2004) [
PubMed: 15266458]
- 24.
Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac.
Annals of Emergency Medicine. 2004;43(2):256–262. (Guideline Ref ID BROUSSEAU2004) [
PubMed: 14747817]
- 25.
Brown JS, Papadopoulos G, Neumann PJ, Price M, Friedman M, Menzin J. Cost-effectiveness of migraine prevention: the case of topiramate in the UK.
Cephalalgia. 2006;26(12):1473–1482. (Guideline Ref ID BROWN2006) [
PubMed: 17116098]
- 26.
Brown JS, Rupnow MF, Neumann P, Friedman M, Menzin J. Cost effectiveness of topiramate in the prevention of migraines in the United States: an update.
Managed Care Interface. 2006;19(12):31–38. (Guideline Ref ID BROWN2006A) [
PubMed: 17274479]
- 27.
Busch V, Gaul C. Exercise in migraine therapy--is there any evidence for efficacy? A critical review.
Headache. 2008;48(6):890–899. (Guideline Ref ID BUSCH2008) [
PubMed: 18572431]
- 28.
Carlsson J, Augustinsson LE, Blomstrand C, Sullivan M. Health status in patients with tension headache treated with acupuncture or physiotherapy.
Headache. 1990;30(9):593–599. (Guideline Ref ID CARLSSON1990) [
PubMed: 2262314]
- 29.
Carlsson J, Fahlcrantz A, Augustinsson LE. Muscle tenderness in tension headache treated with acupuncture or physiotherapy.
Cephalalgia. 1990;10(3):131–141. (Guideline Ref ID CARLSSON1990A) [
PubMed: 2245458]
- 30.
Caro G, Getsios D, Caro JJ, Raggio G, Burrows M, Black L. Sumatriptan: economic evidence for its use in the treatment of migraine, the Canadian comparative economic analysis.
Cephalalgia. 2001;21(1):12–19. (Guideline Ref ID CARO2001) [
PubMed: 11298658]
- 31.
Caro JJ, Getsios D, Raggio G, Caro G, Black L. Treatment of migraine in Canada with naratriptan: a cost-effectiveness analysis.
Headache. 2001;41(5):456–464. (Guideline Ref ID CARO2001A) [
PubMed: 11380643]
- 32.
Cassidy JD, Boyle E, Cote P, He Y, Hogg-Johnson S, Silver FL, et al. Risk of vertebrobasilar stroke and chiropractic care: results of a population-based case-control and case-crossover study.
Spine. 2008;33(4 Suppl):S176–183. (Guideline Ref ID CASSIDY2008) [
PubMed: 18204390]
- 33.
Castien RF, van der Windt DAWM, Grooten A, Dekker J. Effectiveness of manual therapy for chronic tension-type headache: a pragmatic, randomised, clinical trial.
Cephalalgia. 2011;31(2):133–143. (Guideline Ref ID CASTIEN2011) [
PubMed: 20647241]
- 34.
Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
BMJ. 1999;318(7175):13–18. (Guideline Ref ID CHANG1999) [
PMC free article: PMC27668] [
PubMed: 9872876]
- 35.
Chronicle E, Mulleners W. Anticonvulsant drugs for migraine prophylaxis.
Cochrane Database of Systematic Reviews. 2004;(3):CD003226. (Guideline Ref ID CHRONICLE2004) [
PubMed: 15266476]
- 36.
Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.
Archives of Neurology. 2006;63(11):1537–1542. (Guideline Ref ID CITTADINI2006) [
PubMed: 16966497]
- 37.
Coeytaux RR, Frasier PY, Reid A. Patient-centered outcomes for frequent headaches.
Headache. 2007;47(4):480–485. (Guideline Ref ID COEYTAUX2007) [
PubMed: 17445097]
- 38.
Coeytaux RR, Kaufman JS, Chao R, Mann JD, Devellis RF. Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in Headache Impact Test.
Journal of Clinical Epidemiology. 2006;59(4):374–380. (Guideline Ref ID COEYTAUX2006) [
PubMed: 16549259]
- 39.
Coeytaux RR, Kaufman JS, Kaptchuk TJ, Chen W, Miller WC, Callahan LF, et al. A randomized, controlled trial of acupuncture for chronic daily headache.
Headache. 2005;45(9):1113–1123. (Guideline Ref ID COEYTAUX2005) [
PubMed: 16178942]
- 40.
Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial.
Journal of the American Medical Association. 2009;302(22):2451–2457. (Guideline Ref ID COHEN2009) [
PubMed: 19996400]
- 41.
Cole JC, Lin P, Rupnow MF. Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version.
Cephalalgia. 2009;29(11):1180–1187. (Guideline Ref ID COLE2009) [
PubMed: 19830883]
- 42.
Couturier EG, Bomhof MA, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment.
Cephalalgia. 2003;23(4):302–308. (Guideline Ref ID COUTURIER2003) [
PubMed: 12716349]
- 43.
Creac’h C, Frappe P, Cancade M, Laurent B, Peyron R, Demarquay G, et al. In-patient versus out-patient withdrawal programmes for medication overuse headache: a 2-year randomized trial.
Cephalalgia. 2011;31(11):1189–1198. (Guideline Ref ID CREACH2011) [
PubMed: 21700646]
- 44.
Cull RE. Investigation of late-onset migraine.
Scottish Medical Journal. 1995;40(2):50–52. (Guideline Ref ID CULL1995) [
PubMed: 7618069]
- 45.
- 46.
D’Souza PJ, Lumley MA, Kraft CA, Dooley JA. Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial.
Annals of Behavioral Medicine. 2008;36(1):21–32. (Guideline Ref ID DSOUZA2008) [
PMC free article: PMC2931412] [
PubMed: 18696172]
- 47.
Dahlof CG, Jacobs LD. Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache.
Cephalalgia. 1996;16(2):117–123. (Guideline Ref ID DAHLOF1996) [
PubMed: 8665578]
- 48.
Demaerel P, Boelaert I, Wilms G, Baert AL. The role of cranial computed tomography in the diagnostic work-up of headache.
Headache. 1996;36(6):347–348. (Guideline Ref ID DEMAEREL1996) [
PubMed: 8707550]
- 49.
Department of Reproductive Health WHO. Medical eligibility criteria for contraceptive use. 4th edition. World Health Organization; 2009. (Guideline Ref ID WHO2009)
- 50.
Derry S, Moore RA, McQuay HJ. Eletriptan for acute migraine headaches in adults
PROTOCOL.
Cochrane Database of Systematic Reviews. 2010;(4):CD008490. (Guideline Ref ID DERRY2010) [
PMC free article: PMC4176626] [
PubMed: 25267910]
- 51.
Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study.
Clinica Terapeutica. 2000;151(3):145–148. (Guideline Ref ID DITRAPANI2000) [
PubMed: 10958046]
- 52.
Diamond S, Balm TK, Freitag FG. Ibuprofen plus caffeine in the treatment of tension-type headache.
Clinical Pharmacology & Therapeutics. 2000;68(3):312–319. (Guideline Ref ID DIAMOND2000) [
PubMed: 11014413]
- 53.
Diener HC. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
Cephalalgia. 1999;19(6):581–588. (Guideline Ref ID DIENER1999) [
PubMed: 10448545]
- 54.
Diener HC, Bussone G, de LH, Eikermann A, Englert R, Floeter T, et al. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks.
Cephalalgia. 2004;24(11):947–954. (Guideline Ref ID DIENER2004) [
PubMed: 15482357]
- 55.
Diener HC, Eikermann A, Gessner U, Gobel H, Haag G, Lange R, et al. Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms.
European Neurology. 2004;52(1):50–56. (Guideline Ref ID DIENER2004B) [
PubMed: 15240983]
- 56.
Diener HC, Gendolla A, Feuersenger A, Evers S, Straube A, Schumacher H, et al. Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial.
Cephalalgia. 2009;29(9):921–927. (Guideline Ref ID DIENER2009A) [
PubMed: 19250283]
- 57.
Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ, et al. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
European Neurology. 2002;47(2):99–107. (Guideline Ref ID DIENER2002A) [
PubMed: 11844898]
- 58.
Diener HC, Kronfeld K, Boewing G, Lungenhausen M, Maier C, Molsberger A, et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial.
Lancet Neurology. 2006;5(4):310–316. (Guideline Ref ID DIENER2006) [
PubMed: 16545747]
- 59.
Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.
Cephalalgia. 2005;25(10):776–787. (Guideline Ref ID DIENER2005) [
PubMed: 16162254]
- 60.
Diener HC, Rahlfs VW, Danesch U. The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria.
European Neurology. 2004;51(2):89–97. (Guideline Ref ID DIENER2004C) [
PubMed: 14752215]
- 61.
Diener HC, Tfelt-Hansen P, Dahlof C, Lainez MJA, Sandrini G, Wang SJ, et al. Topiramate in migraine prophylaxis: Results from a placebo-controlled trial with propranolol as an active control.
Journal of Neurology. 2004;251(8):943–950. (Guideline Ref ID DIENER2004A) [
PubMed: 15316798]
- 62.
Dousset V, Laporte A, Legoff M, Traineau MH, Dartigues JF, Brochet B. Validation of a brief self-administered questionnaire for cluster headache screening in a tertiary center.
Headache. 2009;49(1):64–70. (Guideline Ref ID DOUSSET2009) [
PubMed: 19133334]
- 63.
Dowson A, Ball K, Haworth D. Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study.
Curr Med Res Opin. 2000;16(3):190–197. (Guideline Ref ID DOWSON2000) [
PubMed: 11191009]
- 64.
Duarte C, Dunaway F, Turner L, Aldag J, Frederick R. Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial.
Annals of Emergency Medicine. 1992;21(9):1116–1121. (Guideline Ref ID DUARTE1992) [
PubMed: 1514724]
- 65.
Dzoljic E, Sipetic S, Vlajinac H, Marinkovic J, Brzakovic B, Pokrajac M, et al. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University.
Headache. 2002;42(3):185–193. (Guideline Ref ID DZOLJIC2002) [
PubMed: 11903541]
- 66.
Ebneshahidi NS, Heshmatipour M, Moghaddami A, Eghtesadi-Araghi P. The effects of laser acupuncture on chronic tension headache - a randomised controlled trial.
Acupuncture in Medicine. 2005;23(1):13–18. (Guideline Ref ID EBNESHAHIDI2005) [
PubMed: 15844435]
- 67.
Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group.
Acta Neurologica Scandinavica. 1993;88(1):63–69. (Guideline Ref ID EKBOM1993) [
PubMed: 8396833]
- 68.
Ekbom K, Waldenlind E, Levi R, Andersson B, Boivie J, Dizdar N, et al. Treatment of acute cluster headache with sumatriptan. New England Journal of Medicine. 1991;325(5):322–326. (Guideline Ref ID EKBOM1991)
- 69.
El Amrani MG. A negative trial of sodium valproate in cluster headache: Methodological issues.
Cephalalgia. 2002;22(3):205–208. (Guideline Ref ID ELAMRANI2002) [
PubMed: 12047460]
- 70.
Elkharrat D, Raphael JC, Korach JM, Jars-Guincestre MC, Chastang C, Harboun C, et al. Acute carbon monoxide intoxication and hyperbaric oxygen in pregnancy.
Intensive Care Medicine. 1991;17(5):289–292. (Guideline Ref ID ELKHARRAT1991) [
PubMed: 1939875]
- 71.
Endres HG, Böwing G, Diener HC, Lange S, Maier C, Molsberger A, et al. Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomised trial.
The Journal of Headache and Pain. 2007;8(5):306–314. (Guideline Ref ID ENDRES2007) [
PMC free article: PMC3476149] [
PubMed: 17955168]
- 72.
Ergun H, Gulmez SE, Tulunay FC. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis.
European Neurology. 2007;58(4):215–217. (Guideline Ref ID ERGUN2007) [
PubMed: 17827966]
- 73.
- 74.
Ertas M, Baykan B, Tuncel D, Gokce M, Gokcay F, Sirin H, et al. A comparative ID migraine screener study in ophthalmology, ENT and neurology out-patient clinics.
Cephalalgia. 2009;29(1):68–75. (Guideline Ref ID ERTAS2009) [
PubMed: 18771489]
- 75.
Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies.
BMJ. 2005;330(7482):63–65. (Guideline Ref ID ETMINAN2005) [
PMC free article: PMC543862] [
PubMed: 15596418]
- 76.
Evans KW, Boan JA, Evans JL, Shuaib A. Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine.
Pharmacoeconomics. 1997;12(5):565–577. (Guideline Ref ID EVANS1997) [
PubMed: 10174323]
- 77.
Facco E, Liguori A, Petti F, Zanette G, Coluzzi F, De Nardin M, et al. Traditional acupuncture in migraine: a controlled, randomized study.
Headache. 2008;48(3):398–407. (Guideline Ref ID FACCO2008) [
PubMed: 17868354]
- 78.
Faculty of Sexual and Reproductive Healthcare. UK Medicial Eligibility Criteria for contraception use. 2009. [Last accessed: 13 July 2012]. (Guideline Ref ID FSRH2009)
- 79.
Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit RCoOaG.
CEU statement:antiepileptic drugs and contraception. 2010. [Last accessed: 1 March 2012]. Available from:
http://www.fsrh.org/pdfs/CEUStatementADC0110.pdf.
(Guideline Ref ID FSRH2010)- 80.
Fogan L. Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation.
Arch Neurol. 1985;42(4):362–363. (Guideline Ref ID FOGAN1985) [
PubMed: 3885921]
- 81.
Foster G, Taylor SJ, Eldridge SE, Ramsay J, Griffiths CJ. Self-management education programmes by lay leaders for people with chronic conditions.
Cochrane Database of Systematic Reviews. 2007;(4):CD005108. (Guideline Ref ID FOSTER2007) [
PubMed: 17943839]
- 82.
Freitag F, Diamond M, Diamond S, Janssen I, Rodgers A, Skobieranda F. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
Headache. 2008;48(6):921–930. (Guideline Ref ID FREITAG2008A) [
PubMed: 18572432]
- 83.
Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
Neurology. 2002;58(11):1652–1659. (Guideline Ref ID FREITAG2002) [
PubMed: 12058094]
- 84.
Friedman AP, DiSerio FJ. Symptomatic treatment of chronically recurring tension headache: a placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine.
Clinical Therapeutics. 1987;10(1):69–81. (Guideline Ref ID FRIEDMAN1987) [
PubMed: 3329967]
- 85.
Friedman BW, Corbo J, Lipton RB, Bijur PE, Esses D, Solorzano C, et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines.
Neurology. 2005;64(3):463–468. (Guideline Ref ID FRIEDMAN2005) [
PubMed: 15699376]
- 86.
Fumal A, Schoenen J. Tension-type headache: current research and clinical management.
Lancet Neurology. 2008;7(1):70–83. (Guideline Ref ID FUMAL2008) [
PubMed: 18093564]
- 87.
Gelmers HJ, Henry P, Lucas J, Holt-Larsen B, Olesen J, Behan P, et al. European multicenter trial of Nimodipine in the prophylaxis of common migraine (migraine without aura).
Headache. 1989;29(10):633–638. (Guideline Ref ID GELMERS1989A) [
PubMed: 2693405]
- 88.
Gelmers HJ, Henry P, Lucas J, Holt-Larsen B, Olesen J, Behan P, et al. European multicenter trial of Nimodipine in the prophylaxis of classic migraine (migraine with aura).
Headache. 1989;29(10):639–642. (Guideline Ref ID GELMERS1989) [
PubMed: 2693406]
- 89.
Gifford AL, Hecht FM. Evaluating HIV-infected patients with headache: who needs computed tomography?
Headache. 2001;41(5):441–448. (Guideline Ref ID GIFFORD2001) [
PubMed: 11380641]
- 90.
Gil-Gouveia R, Martins I. Validation of the Portuguese version of ID-Migraine.
Headache. 2010;50(3):396–402. (Guideline Ref ID GILGOUVEIA2010) [
PubMed: 19473280]
- 91.
Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM, et al. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
Headache. 2005;45(8):973–982. (Guideline Ref ID GOLDSTEIN2005) [
PubMed: 16109110]
- 92.
Goldstein J, Silberstein SD, Saper JR, Ryan RE Jr, Lipton RB. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study.
Headache. 2006;46(3):444–453. (Guideline Ref ID GOLDSTEIN2006) [
PubMed: 16618262]
- 93.
GRADE Working Group.
Grading of Recommendations Assessment, Development and Evaluation working group. 2011. Available from:
http://www.gradeworkinggroup.org/ (Guideline Ref ID 16045)- 94.
Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.
Headache. 1993;33(7):385–389. (Guideline Ref ID GRANELLA1993) [
PubMed: 8376100]
- 95.
Grimaldi D, Nonino F, Cevoli S, Vandelli A, D’Amico R, Cortelli P. Risk stratification of non-traumatic headache in the emergency department.
Journal of Neurology. 2009;256(1):51–57. (Guideline Ref ID GRIMALDI2009) [
PubMed: 19221851]
- 96.
Grossmann M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine.
International Journal of Clinical Pharmacology and Therapeutics. 2000;38(9):430–435. (Guideline Ref ID GROSSMANN2000) [
PubMed: 11020030]
- 97.
Hagen K, Albretsen C, Vilming ST, Salvesen R, Gronning M, Helde G, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial.
Cephalalgia. 2009;29(2):221–232. (Guideline Ref ID HAGEN2009) [
PubMed: 18823363]
- 98.
Headache Classification Subcommittee of the InternationalHeadache Society (IHS). The International Classification of Headache Disorders (2nd edn).
Cephalalgia. 2004;24(Suppl 1):1–160. (Guideline Ref ID IHS2004) [
PubMed: 14979299]
- 99.
HeadSmart. HeadSmart: be brain tumour aware. 2011. [Last accessed: 13 July 2012]. (Guideline Ref ID HEADSMART2011)
- 100.
Health and Safety Executive. Gas health and safety. 2012. [Last accessed: 13 July 2012]. (Guideline Ref ID HSE)
- 101.
Health and Social Care Information Centre, NHS Information Centre.
HESonline: hospital episode statistics. 2011. [Last accessed: 21 September 2011]. Available from:
http://www.hesonline.nhs.uk/ (Guideline Ref ID HES2011)- 102.
Henderson J. Migraine in women twenty-six to forty-five years of age.
Australian Journal of Holistic Nursing. 1999;6(2):10–19. (Guideline Ref ID HENDERSON1999) [
PubMed: 11898205]
- 103.
Hesse J, Møgelvang B, Simonsen H. Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation.
Journal of Internal Medicine. 1994;235(5):451–456. (Guideline Ref ID HESSE1994) [
PubMed: 8182401]
- 104.
Holroyd KA, Cottrell CK, O’Donnell FJ, Cordingley GE, Drew JB, Carlson BW, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.
BMJ. 2010;341:c4871. (Guideline Ref ID HOLROYD2010) [
PMC free article: PMC2947621] [
PubMed: 20880898]
- 105.
Howard L, Wessely S, Leese M, Page L, McCrone P, Husain K, et al. Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache.
Journal of Neurology, Neurosurgery and Psychiatry. 2005;76(11):1558–1564. (Guideline Ref ID HOWARD2005) [
PMC free article: PMC1739391] [
PubMed: 16227551]
- 106.
International Headache Society. IHS Classification (ICHD-2). 2004. [Last accessed: 17 May 11 A.D]. (Guideline Ref ID ICHD2004)
- 107.
Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference.
Controlled Clinical Trials. 1989;10(4):407–415. (Guideline Ref ID 20248) [
PubMed: 2691207]
- 108.
Jensen R, Tassorelli C, Rossi P, Allena M, Osipova V, Steiner T, et al. A basic diagnostic headache diary (BDHD) is well accepted and useful in the diagnosis of headache. a multicentre European and Latin American study.
Cephalalgia. 2011;31(15):1549–1560. (Guideline Ref ID JENSEN2011) [
PubMed: 22019575]
- 109.
Jette N, Patten S, Williams J, Becker W, Wiebe S. Comorbidity of migraine and psychiatric disorders--a national population-based study.
Headache. 2008;48(4):501–516. (Guideline Ref ID JETTE2008) [
PubMed: 18070059]
- 110.
John PJ, Sharma N, Sharma CM, Kankane A. Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial.
Headache. 2007;47(5):654–661. (Guideline Ref ID JOHN2007) [
PubMed: 17501846]
- 111.
Joint Formulary Committee.
British National Formulary (BNF). 62nd edition. London: British Medical Association and The Royal Pharmaceutical Society of Great Britain; 2011. Available from:
http://www.bnf.org.uk.
(Guideline Ref ID BNF2011)- 112.
Joint Formulary Committee. British National Formulary (BNF). 61st edition. London: British Medical Association and The Royal Pharmaceutical Society of Great Britain; 2011. (Guideline Ref ID BNF2011A)
- 113.
Jordan JE, Ramirez GF, Bradley WG, Chen DY, Lightfoote JB, Song A. Economic and outcomes assessment of magnetic resonance imaging in the evaluation of headache.
Journal of the National Medical Association. 2000;92(12):573–578. (Guideline Ref ID JORDAN2000) [
PMC free article: PMC2568332] [
PubMed: 11202760]
- 114.
Kahn CEJ, Sanders GD, Lyons EA, Kostelic JK, MacEwan DW, Gordon WL. Computed tomography for nontraumatic headache: current utilization and cost-effectiveness.
Canadian Association of Radiologists Journal. 1993;44(3):189–193. (Guideline Ref ID KAHN1993) [
PubMed: 8504331]
- 115.
Karabetsos A, Karachalios G, Bourlinou P, Reppa A, Koutri R, Fotiadou A. Ketoprofen versus paracetamol in the treatment of acute migraine.
Headache. 1997;37(1):12–14. (Guideline Ref ID KARABETSOS1997) [
PubMed: 9046717]
- 116.
Karachalios GN, Fotiadou A, Chrisikos N, Karabetsos A, Kehagioglou K. Treatment of acute migraine attack with diclofenac sodium: a double-blind study.
Headache. 1992;32(2):98–100. (Guideline Ref ID KARACHALIOS1992) [
PubMed: 1551795]
- 117.
Karli N, Ertas M, Baykan B, Uzunkaya O, Saip S, Zarifoglu M, et al. The validation of ID Migraine screener in neurology outpatient clinics in Turkey.
J Headache Pain. 2007;8(4):217–223. (Guideline Ref ID KARLI2007) [
PMC free article: PMC3451667] [
PubMed: 17901923]
- 118.
Karst M, Reinhard M, Thum P, Wiese B, Rollnik J, Fink M. Needle acupuncture in tension-type headache: a randomized, placebo-controlled study.
Cephalalgia. 2001;21(6):637–642. (Guideline Ref ID KARST2001) [
PubMed: 11531895]
- 119.
Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers.
Journal of the American Medical Association. 1999;282(1):36–39. (Guideline Ref ID KATZMAN1999) [
PubMed: 10404909]
- 120.
Kernick D, Stapley S, Campbell J, Hamilton W. What happens to new-onset headache in children that present to primary care? A case-cohort study using electronic primary care records.
Cephalalgia. 2009;29(12):1311–1316. (Guideline Ref ID KERNICK2009) [
PubMed: 19911465]
- 121.
Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records.
Cephalalgia. 2008;28(11):1188–1195. (Guideline Ref ID KERNICK2008A) [
PubMed: 18771496]
- 122.
Kernick D, Stapley S, Hamilton W. GPs’ classification of headache: is primary headache underdiagnosed?
British Journal of General Practice. 2008;58(547):102–104. (Guideline Ref ID KERNICK2008B) [
PMC free article: PMC2233960] [
PubMed: 18307854]
- 123.
Kernick DP, Ahmed F, Bahra A, Dowson A, Elrington G, Fontebasso M, et al. Imaging patients with suspected brain tumour: guidance for primary care.
British Journal of General Practice. 2008;58(557):880–885. (Guideline Ref ID KERNICK2008) [
PMC free article: PMC2593538] [
PubMed: 19068162]
- 124.
Khu JV, Siow HC, Ho KH. Headache diagnosis, management and morbidity in the Singapore primary care setting: findings from a general practice survey.
Singapore Medical Journal. 2008;49(10):774–779. (Guideline Ref ID KHU2008) [
PubMed: 18946609]
- 125.
Kim ST, Kim CY. Use of the ID Migraine questionnaire for migraine in TMJ and Orofacial Pain Clinic.
Headache. 2006;46(2):253–258. (Guideline Ref ID KIM2006) [
PubMed: 16492234]
- 126.
Kirthi V, Derry S, Moore RA, McQuay HJ. Aspirin with or without an antiemetic for acute migraine headaches in adults.
Cochrane Database of Systematic Reviews. 2010;(4):CD008041. (Guideline Ref ID KIRTHI2010) [
PMC free article: PMC4163048] [
PubMed: 20393963]
- 127.
Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
Cephalalgia. 1997;17(2):103–108. [Erratum appears in Cephalalgia 1997 Nov;17(7):798]
(Guideline Ref ID KLAPPER1997) [
PubMed: 9137847]
- 128.
Kohlenberg RJ, Cahn T. Self-help treatment for migraine headaches: A controlled outcome study.
Headache. 1981;21(5):196–200. (Guideline Ref ID KOHLENBERG1981) [
PubMed: 7287417]
- 129.
Koren G, Sharav T, Pastuszak A, Garrettson LK, Hill K, Samson I, et al. A multicenter, prospective study of fetal outcome following accidental carbon monoxide poisoning in pregnancy.
Reproductive Toxicology. 1991;5(5):397–403. (Guideline Ref ID KOREN1991) [
PubMed: 1806148]
- 130.
Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.
Annals of Internal Medicine. 2007;146(5):317–325. (Guideline Ref ID KROENKE2007) [
PubMed: 17339617]
- 131.
Kubitzek F, Ziegler G, Gold MS, Liu JM, Ionescu E. Low-dose diclofenac potassium in the treatment of episodic tension-type headache.
European Journal of Pain. 2003;7(2):155–162. (Guideline Ref ID KUBITZEK2003) [
PubMed: 12600797]
- 132.
Kudrow L. Response of cluster headache attacks to oxygen inhalation.
Headache. 1981;21(1):1–4. (Guideline Ref ID KUDROW1981) [
PubMed: 7007285]
- 133.
Lainez MJ, Galvan J, Heras J, Vila C. Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.
European Journal of Neurology. 2007;14(3):269–275. (Guideline Ref ID LAINEZ2007A) [
PubMed: 17355546]
- 134.
Lambeth Practice Based Commissioning Collaborative (LPBCC). (Guideline Ref ID LAMBETH2011)
- 135.
Larson EB. Diagnostic evaluation of headache. Impact of computerized tomography and cost-effectiveness.
Journal of the American Medical Association. 1980;243(4):359–362. (Guideline Ref ID LARSON1980) [
PubMed: 6766193]
- 136.
Larsson B, Daleflod B, Hakansson L, Melin L. Therapist-assisted versus self-help relaxation treatment of chronic headaches in adolescents: a school-based intervention.
Journal of Child Psychology & Psychiatry & Allied Disciplines. 1987;28(1):127–136. (Guideline Ref ID LARSSON1987) [
PubMed: 3104371]
- 137.
Larsson B, Melin L. Chronic headaches in adolescents: treatment in a school setting with relaxation training as compared with information-contact and self-registration.
Pain. 1986;25(3):325–336. (Guideline Ref ID LARSSON1986) [
PubMed: 3528989]
- 138.
Latinovic R, Gulliford M, Ridsdale L. Headache and migraine in primary care: consultation, prescription, and referral rates in a large population.
Journal of Neurology, Neurosurgery and Psychiatry. 2006;77(3):385–387. (Guideline Ref ID LATINOVIC2006) [
PMC free article: PMC2077680] [
PubMed: 16484650]
- 139.
Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study.
Neurology. 1999;53(3):537–542. (Guideline Ref ID LAUNER1999) [
PubMed: 10449117]
- 140.
- 141.
Le Jeunne C, Gomez JP, Pradalier A, Albareda F, Joffroy A, Liano H, et al. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
European Neurology. 1999;41(1):37–43. (Guideline Ref ID LEJEUNE1999) [
PubMed: 9885327]
- 142.
Lemstra M, Stewart B, Olszynski WP. Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial.
Headache. 2002;42(9):845–854. (Guideline Ref ID LEMSTRA2002) [
PubMed: 12390609]
- 143.
Leone M, D’Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo.
Neurology. 2000;54(6):1382–1385. (Guideline Ref ID LEONE2000) [
PubMed: 10746617]
- 144.
Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups.
Cephalalgia. 1996;16(7):494–496. (Guideline Ref ID LEONE1996) [
PubMed: 8933994]
- 145.
Lewis DW, Dorbad D. The utility of neuroimaging in the evaluation of children with migraine or chronic daily headache who have normal neurological examinations.
Headache. 2000;40(8):629–632. (Guideline Ref ID LEWIS2000) [
PubMed: 10971658]
- 146.
Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
Pediatrics. 2009;123(3):924–934. (Guideline Ref ID LEWIS2009) [
PubMed: 19255022]
- 147.
Li Y, Zheng H, Witt CM, Roll S, Yu Sg, Yan J, et al. Acupuncture for migraine prophylaxis: a randomized controlled trial.
Canadian Medical Association Journal. 2012. (Guideline Ref ID LI2012) [
PMC free article: PMC3291669] [
PubMed: 22231691]
- 148.
Lidegaard O. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease.
British Journal of Obstetrics and Gynaecology. 1995;102(2):153–159. (Guideline Ref ID LIDEGAARD1995) [
PubMed: 7756208]
- 149.
Lidegaard O, Kreiner S. Contraceptives and cerebral thrombosis: a five-year national case-control study.
Contraception. 2002;65(3):197–205. (Guideline Ref ID LIDEGAARD2002) [
PubMed: 11929641]
- 150.
Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis.
Cochrane Database of Systematic Reviews. 2009;(1):CD001218. (Guideline Ref ID LINDE2009A) [
PMC free article: PMC3099267] [
PubMed: 19160193]
- 151.
Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for tension-type headache.
Cochrane Database of Systematic Reviews. 2009;(1):CD007587. (Guideline Ref ID LINDE2009) [
PMC free article: PMC3099266] [
PubMed: 19160338]
- 152.
Linde K, Rossnagel K. Propranolol for migraine prophylaxis.
Cochrane Database of Systematic Reviews. 2004;(2):CD003225. (Guideline Ref ID LINDE2004) [
PubMed: 15106196]
- 153.
Linde K, Streng A, Jurgens S, Hoppe A, Brinkhaus B, Witt C, et al. Acupuncture for patients with migraine: a randomized controlled trial.
Journal of the American Medical Association. 2005;293(17):2118–2125. (Guideline Ref ID LINDE2005) [
PubMed: 15870415]
- 154.
Lipton RB, Amatniek J, Ferrari MD, Gross M. Migraine: identifying and removing barriers to care.
Neurology. 1994;44(Suppl 4):63–68. (Guideline Ref ID LIPTON1994) [
PubMed: 8008228]
- 155.
Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study.
Neurology. 2003;61(3):375–382. (Guideline Ref ID LIPTON2003B) [
PubMed: 12913201]
- 156.
Lipton RB, Göbel H, Einhäupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine.
Neurology. 2004;63(12):2240–2244. (Guideline Ref ID LIPTON2004) [
PubMed: 15623680]
- 157.
Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, et al. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
Cephalalgia. 2011;31(1):18–30. (Guideline Ref ID LIPTON2011) [
PubMed: 20974598]
- 158.
Loder E. Cluster headache from the patient’s point of view.
Current Pain and Headache Reports. 2005;9(2):120–125. (Guideline Ref ID LODER2005) [
PubMed: 15745622]
- 159.
Lofland JH, Kim SS, Batenhorst AS, Johnson NE, Chatterton ML, Cady RK, et al. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine.
Mayo Clinic Proceedings. 2001;76(11):1093–1101. (Guideline Ref ID LOFLAND2001) [
PubMed: 11702897]
- 160.
MacGregor EA, Brandes J, Eikermann A, Giammarco R. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
Current Medical Research and Opinion. 2004;20(7):1143–1150. (Guideline Ref ID MACGREGOR2004) [
PubMed: 15265259]
- 161.
MacGregor EA, Chia H, Vohrah RC, Wilkinson M. Migraine and menstruation: a pilot study.
Cephalalgia. 1990;10(6):305–310. (Guideline Ref ID MACGREGOR1990) [
PubMed: 2289231]
- 162.
MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle.
Neurology. 2004;63(2):351–353. (Guideline Ref ID MACGREGOR2004A) [
PubMed: 15277635]
- 163.
MacGregor EA, Igarashi H, Wilkinson M. Headaches and hormones: subjective versus objective assessment. Headache Quarterly. 1997;8:126–136. (Guideline Ref ID MACGREGOR1997)
- 164.
Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy.
Cephalalgia. 1997;17(7):765–769. (Guideline Ref ID MAGGIONI1997) [
PubMed: 9399007]
- 165.
Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, et al. Migraine prophylaxis with divalproex.
Archives of Neurology. 1995;52(3):281–286. (Guideline Ref ID MATHEW1995) [
PubMed: 7872882]
- 166.
McCormick A, Fleming D, Charlton J. Royal College of General Practitioners, Office of Population of Census and Surveys. Morbidity statistics from general practice: fourth national study 1991–1992. London: HMSO; 1995. (Guideline Ref ID MCCORMICK1995)
- 167.
McCrory DC, Gray RN. Oral sumatriptan for acute migraine.
Cochrane Database of Systematic Reviews. 2003;(3):CD002915. (Guideline Ref ID MCCRORY2003) [
PubMed: 12917936]
- 168.
Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA. Exercise for depression.
Cochrane Database of Systematic Reviews. 2009;(3):CD004366. (Guideline Ref ID MEAD2009) [
PubMed: 19588354]
- 169.
Mehlisch DR, Weaver M, Fladung B. Ketoprofen, acetaminophen, and placebo in the treatment of tension headache.
Headache. 1998;38(8):579–589. (Guideline Ref ID MEHLISCH1998) [
PubMed: 11398300]
- 170.
Mei D, Capuano A, Vollono C, Evangelista M, Ferraro D, Tonali P, et al. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.
Neurological Sciences. 2004;25(5):245–250. (Guideline Ref ID MEI2004) [
PubMed: 15624081]
- 171.
Melchart D, Streng A, Hoppe A, Brinkhaus B, Witt C, Wagenpfeil S, et al. Acupuncture in patients with tension-type headache: randomised controlled trial.
BMJ (Clinical Research Ed). 2005;331(7513):376–382. (Guideline Ref ID MELCHART2005) [
PMC free article: PMC1184247] [
PubMed: 16055451]
- 172.
Meyer GA. The art of watching out: vigilance in women who have migraine headaches.
Qualitative Health Research. 2002;12(9):1220–1234. (Guideline Ref ID MEYER2002) [
PubMed: 12448668]
- 173.
Misra UK, Kalita J, Yadav RK. Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial.
J Headache Pain. 2007;8(3):175–179. (Guideline Ref ID MISRA2007) [
PMC free article: PMC3476139] [
PubMed: 17563841]
- 174.
Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches.
Cochrane Database of Systematic Reviews. 2005;(3):CD002919. (Guideline Ref ID MOJA2005) [
PubMed: 16034880]
- 175.
Moloney MF, Strickland OL, De Rossett SE, Melby MK, Dietrich AS. The experiences of midlife women with migraines.
Journal of Nursing Scholarship. 2006;38(3):278–285. (Guideline Ref ID MOLONEY2006) [
PubMed: 17044346]
- 176.
Monstad I, Krabbe A, Micieli G, Prusinski A, Cole J, Pilgrim A, et al. Preemptive oral treatment with sumatriptan during a cluster period.
Headache. 1995;35(10):607–613. (Guideline Ref ID MONSTAD1995) [
PubMed: 8550362]
- 177.
Morris Z, Whiteley WN, Longstreth WT Jr, Weber F, Lee YC, Tsushima Y, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis.
BMJ (Clinical Research Ed). 2009;339:b3016. (Guideline Ref ID MORRIS2009) [
PMC free article: PMC2728201] [
PubMed: 19687093]
- 178.
Mostardini C, d’Agostino VC, Dugoni DE, Cerbo R. A possible role of ID-Migraine in the emergency department: study of an emergency department out-patient population.
Cephalalgia. 2009;29(12):1326–1330. (Guideline Ref ID MOSTARDINI2009) [
PubMed: 19438919]
- 179.
Myllyla VV, Havanka H, Herrala L, Kangasniemi P, Rautakorpi I, Turkka J, et al. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study.
Headache. 1998;38(3):201–207. (Guideline Ref ID MYLLYLA1998) [
PubMed: 9563211]
- 180.
- 181.
- 182.
Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache.
Journal of Manipulative and Physiological Therapeutics. 1998;21(8):511–519. (Guideline Ref ID NELSON1998A) [
PubMed: 9798179]
- 183.
Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG, et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
Headache. 2001;41(3):248–256. (Guideline Ref ID NEWMAN2001) [
PubMed: 11264684]
- 184.
Nezvalova-Henriksen K, Spigset O, Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study.
Headache. 2010;50(4):563–575. (Guideline Ref ID NEZVALOVA2010) [
PubMed: 20132339]
- 185.
- 186.
O’Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: a population-based survey.
International Journal of Epidemiology. 1994;23(5):1020–1026. (Guideline Ref ID OBRIEN1994) [
PubMed: 7860153]
- 187.
Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. Pregnancy outcome following prescription for sumatriptan.
Headache. 2000;40(1):20–24. (Guideline Ref ID OLESEN2000) [
PubMed: 10759898]
- 188.
Packard RC. What does the headache patient want?
Headache. 1979;19(7):370–374. (Guideline Ref ID PACKARD1979) [
PubMed: 511538]
- 189.
Packman B, Packman E, Doyle G, Cooper S, Ashraf E, Koronkiewicz K, et al. Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache.
Headache. 2000;40(7):561–567. (Guideline Ref ID PACKMAN2000) [
PubMed: 10940094]
- 190.
Pageler L, Katsarava Z, Lampl C, Straube A, Evers S, Diener HC, et al. Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design.
Headache. 2011;51(1):129–134. (Guideline Ref ID PAGELER2011) [
PubMed: 21198573]
- 191.
Pageler L, Savidou I, Limmroth V. Medication-overuse headache.
Current Pain and Headache Reports. 2005;9(6):430–435. (Guideline Ref ID PAGELER2005) [
PubMed: 16282044]
- 192.
Patterson VH, Esmonde TF. Comparison of the handling of neurological outpatient referrals by general physicians and a neurologist.
Journal of Neurology, Neurosurgery and Psychiatry. 1993;56(7):830. (Guideline Ref ID PATTERSON1993) [
PMC free article: PMC1015070] [
PubMed: 8331364]
- 193.
Payne K, Kozma CM, Lawrence BJ. Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine: a retrospective cost-efficacy analysis.
Pharmacoeconomics. 1996;10(1):59–71. (Guideline Ref ID PAYNE1996) [
PubMed: 10160470]
- 194.
Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study.
Cephalalgia. 1996;16(4):257–263. (Guideline Ref ID PEIKERT1996) [
PubMed: 8792038]
- 195.
Peters M, Abu-Saad HH, Vydelingum V, Dowson A, Murphy M. Patients’ decision-making for migraine and chronic daily headache management. A qualitative study.
Cephalalgia. 2003;23(8):833–841. (Guideline Ref ID PETERS2003) [
PubMed: 14510931]
- 196.
Peters M, Abu-Saad HH, Vydelingum V, Dowson A, Murphy M. Migraine and chronic daily headache management: a qualitative study of patients’ perceptions.
Scandinavian Journal of Caring Sciences. 2004;18(3):294–303. (Guideline Ref ID PETERS2004) [
PubMed: 15355524]
- 197.
Pfaffenrath V, Diener HC. Amitriptyline versus amitriptyline-N-oxide versus placebo in the treatment of chronic tension type headache: A multi-centre, randomised parallel-group double-blind study. Cephalalgia. 1991;11(SUPPL 11):329–330. (Guideline Ref ID PFAFFENRATH1991)
- 198.
Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-Von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis - A double-blind, multicentre, randomized placebo-controlled dose-response study.
Cephalalgia. 2002;22(7):523–532. (Guideline Ref ID PFAFFENRATH2002) [
PubMed: 12230594]
- 199.
Pfaffenrath V, Diener HC, Isler H, Meyer C, Scholz E, Taneri Z, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study.
Cephalalgia. 1994;14(2):149–155. (Guideline Ref ID PFAFFENRATH1994) [
PubMed: 8062354]
- 200.
Phillip D, Lyngberg A, Jensen R. Assessment of headache diagnosis. A comparative population study of a clinical interview with a diagnostic headache diary.
Cephalalgia. 2007;27(1):1–8. (Guideline Ref ID PHILLIP2007) [
PubMed: 17212676]
- 201.
Pini LA, Del BE, Zanchin G, Sarchielli P, Di TG, Prudenzano MP, et al. Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium.
Journal of Headache & Pain. 2008;9(6):367–373. (Guideline Ref ID PINI2008) [
PMC free article: PMC3452084] [
PubMed: 18815727]
- 202.
Pittler MH, Ernst E. Feverfew for preventing migraine.
Cochrane Database of Systematic Reviews. 2004;(1):CD002286. (Guideline Ref ID PITTLER2004) [
PubMed: 14973986]
- 203.
Porter D, Leviton A, Slack WV, Graham JR. A headache chronicle: the daily recording of headaches and their correlates.
Journal of Chronic Diseases. 1981;34(9–10):481–486. (Guideline Ref ID PORTER1981) [
PubMed: 7276138]
- 204.
Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson C, et al. Long-acting propranolol in migraine prophylaxis: Results of a double-blind, placebo-controlled study.
Cephalalgia. 1989;9(4):247–253. (Guideline Ref ID PRADALIER1989A) [
PubMed: 2692838]
- 205.
Prior MJ, Cooper KM, May LG, Bowen DL. Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial.
Cephalalgia. 2002;22(9):740–748. (Guideline Ref ID PRIOR2002) [
PubMed: 12421160]
- 206.
Rabbie R, Derry S, Moore RA, McQuay HJ. Ibuprofen with or without an antiemetic for acute migraine headaches in adults.
Cochrane Database of Systematic Reviews. 2010;(10):CD008039. (Guideline Ref ID RABBIE2010A) [
PMC free article: PMC4161114] [
PubMed: 20927770]
- 207.
Raieli V, Compagno A, Pandolfi E, La Vecchia M, Puma D, La Franca G, et al. Headache: what do children and mothers expect from pediatricians?
Headache. 2010;50(2):290–300. (Guideline Ref ID RAIELI2010) [
PubMed: 20039963]
- 208.
Ramacciotti AS, Soares BG, Atallah AN. Dipyrone for acute primary headaches.
Cochrane Database of Systematic Reviews. 2007;(2):CD004842. (Guideline Ref ID RAMACCIOTTI2007) [
PubMed: 17443558]
- 209.
Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, et al. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
Neurology. 2007;69(9):821–826. (Guideline Ref ID RAPOPORT2007) [
PubMed: 17724283]
- 210.
Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population--a prevalence study.
Journal of Clinical Epidemiology. 1991;44(11):1147–1157. (Guideline Ref ID RASMUSSEN1991A) [
PubMed: 1941010]
- 211.
Richter IL, McGrath PJ, Humphreys PJ, Goodman JT, Firestone P, Keene D. Cognitive and relaxation treatment of paediatric migraine.
Pain. 1986;25(2):195–203. (Guideline Ref ID RICHTER1986) [
PubMed: 3523394]
- 212.
Ridsdale L, Clark LV, Dowson AJ, Goldstein LH, Jenkins L, McCrone P, et al. How do patients referred to neurologists for headache differ from those managed in primary care?
British Journal of General Practice. 2007;57(538):388–395. (Guideline Ref ID RIDSDALE2007) [
PMC free article: PMC2047014] [
PubMed: 17504590]
- 213.
Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs.
Cephalalgia. 2006;26(9):1097–1105. (Guideline Ref ID ROSSI2006) [
PubMed: 16919060]
- 214.
Rossi P, Faroni JV, Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study.
Cephalalgia. 2008;28(11):1196–1200. (Guideline Ref ID ROSSI2008) [
PubMed: 18727648]
- 215.
Rozen TD. Migraine prevention: what patients want from medication and their physicians (a headache specialty clinic perspective).
Headache. 2006;46(5):750–753. (Guideline Ref ID ROZEN2006) [
PubMed: 16643577]
- 216.
Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen RA, Olesen J. Presentation of a new instrument: the diagnostic headache diary.
Cephalalgia. 1992;12(6):369–374. (Guideline Ref ID RUSSELL1992) [
PubMed: 1473140]
- 217.
Samaan Z, MacGregor EA, Andrew D, McGuffin P, Farmer A. Diagnosing migraine in research and clinical settings: the validation of the Structured Migraine Interview (SMI).
BMC Neurology. 2010;10:7. (Guideline Ref ID SAMAAN2010) [
PMC free article: PMC2824671] [
PubMed: 20074361]
- 218.
Sargent JD, Peters K, Goldstein J, Madison DS, Solbach P. Naproxen sodium for muscle contraction headache treatment.
Headache. 1988;28(3):180–182. (Guideline Ref ID SARGENT1988) [
PubMed: 3290156]
- 219.
Schachtel BP, Thoden WR. Onset of action of ibuprofen in the treatment of muscle-contraction headache.
Headache. 1988;28(7):471–474. (Guideline Ref ID SCHACHTEL1988) [
PubMed: 3072316]
- 220.
Schoenen J, De KN, Giurgea S, Herroelen L, Jacquy J, Louis P, et al. Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia.
Cephalalgia. 2008;28(10):1095–1105. (Guideline Ref ID SCHOENEN2008) [
PubMed: 18644036]
- 221.
Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.
Neurology. 1998;50(2):466–470. (Guideline Ref ID SCHOENEN1998) [
PubMed: 9484373]
- 222.
- 223.
Schunemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ).
COPD: Journal of Chronic Obstructive Pulmonary Disease. 2005;2(1):81–89. (Guideline Ref ID 16044) [
PubMed: 17136967]
- 224.
Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of headache in adults. 2008. [Last accessed: 25 March 2010]. (Guideline Ref ID SIGN2008)
- 225.
Sempere AP, Porta-Etessam J, Medrano V, Garcia-Morales I, Concepcion L, Ramos A, et al. Neuroimaging in the evaluation of patients with non-acute headache.
Cephalalgia. 2005;25(1):30–35. (Guideline Ref ID SEMPERE2005) [
PubMed: 15606567]
- 226.
Shanklin DR, Wolfson SL. Therapeutic oxygen as a possible cause of pulmonary hemorrhage in premature infants.
New England Journal of Medicine. 1967;277(16):833–837. (Guideline Ref ID SHANKLIN1967) [
PubMed: 4859948]
- 227.
Shuhaiber S, Pastuszak A, Schick B, Matsui D, Spivey G, Brochu J, et al. Pregnancy outcome following first trimester exposure to sumatriptan.
Neurology. 1998;51(2):581–583. (Guideline Ref ID SHUHAIBER1998) [
PubMed: 9710039]
- 228.
Sicuteri F, Geppetti P, Marabini S, Lembeck F. Pain relief by somatostatin in attacks of cluster headache.
Pain. 1984;18(4):359–365. (Guideline Ref ID SICUTERI1984) [
PubMed: 6145138]
- 229.
Silberstein S, Saper J, Berenson F, Somogyi M, McCague K, D’Souza J. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
Neurology. 2008;70(7):548–555. (Guideline Ref ID SILBERSTEIN2008A) [
PubMed: 18268247]
- 230.
Silberstein SD. Migraine and pregnancy.
Neurologic Clinics. 1997;15(1):209–231. (Guideline Ref ID SILBERSTEIN1997) [
PubMed: 9058407]
- 231.
Silberstein SD, Hulihan J, Rezaul Karim M, Wu SC, Jordan D, Karvois D, et al. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: A randomized, placebo-controlled, double-blind, 12-week pilot study.
Clinical Therapeutics. 2006;28(7):1002–1011. (Guideline Ref ID SILBERSTEIN2006A) [
PubMed: 16990078]
- 232.
Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial.
Headache. 2007;47(2):170–180. (Guideline Ref ID SILBERSTEIN2007A) [
PubMed: 17300356]
- 233.
Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S. The impact of migraine on daily activities: effect of topiramate compared with placebo.
Current Medical Research & Opinion. 2006;22(6):1021–1029. (Guideline Ref ID SILBERSTEIN2006) [
PubMed: 16846536]
- 234.
Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: Results of a large controlled trial.
Archives of Neurology. 2004;61(4):490–495. (Guideline Ref ID SILBERSTEIN2004B) [
PubMed: 15096395]
- 235.
Singer EJ, Kim J, Fahy-Chandon B, Datt A, Tourtellotte WW. Headache in ambulatory HIV-1-infected men enrolled in a longitudinal study.
Neurology. 1996;47(2):487–494. (Guideline Ref ID SINGER1996) [
PubMed: 8757026]
- 236.
Singer EJ, Zorilla C, Fahy-Chandon B, Chi S, Syndulko K, Tourtellotte WW. Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study.
Pain. 1993;54(1):15–19. (Guideline Ref ID SINGER1993) [
PubMed: 8378098]
- 237.
Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Headache. 2005;45(8):983–991. (Guideline Ref ID SMITH2005) [
PubMed: 16109111]
- 238.
Steiner TJ, Findley LJ, Yuen AWC. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura.
Cephalalgia. 1997;17(2):109–112. (Guideline Ref ID STEINER1997) [
PubMed: 9137848]
- 239.
Steiner TJ, Lange R. Ketoprofen (25 mg) in the symptomatic treatment of episodic tension-type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg).
Cephalalgia. 1998;18(1):38–43. (Guideline Ref ID STEINER1998) [
PubMed: 9601623]
- 240.
Steiner TJ, Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol.
Cephalalgia. 2003;23(1):59–66. (Guideline Ref ID STEINER2003) [
PubMed: 12534583]
- 241.
Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity.
Cephalalgia. 2003;23(7):519–527. (Guideline Ref ID STEINER2003A) [
PubMed: 12950377]
- 242.
Stewart WF, Linet MS, Celentano DD, Van NM, Ziegler D. Age- and sex-specific incidence rates of migraine with and without visual aura.
American Journal of Epidemiology. 1991;134(10):1111–1120. (Guideline Ref ID STEWART1991) [
PubMed: 1746521]
- 243.
Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.
Journal of the American Medical Association. 1992;267(1):64–69. (Guideline Ref ID STEWART1992) [
PubMed: 1727198]
- 244.
- 245.
Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide.
Cephalalgia. 2007;27(3):193–210. (Guideline Ref ID STOVNER2007) [
PubMed: 17381554]
- 246.
Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy.
Cephalalgia. 1999;19(1):44–49. (Guideline Ref ID SUHR1999) [
PubMed: 10099859]
- 247.
Tassorelli C, Sances G, Allena M, Ghiotto N, Bendtsen L, Olesen J, et al. The usefulness and applicability of a basic headache diary before first consultation: results of a pilot study conducted in two centres.
Cephalalgia. 2008;28(10):1023–1030. (Guideline Ref ID TASSORELLI2008) [
PubMed: 18624804]
- 248.
Tepper SJ, Dahlof CG, Dowson A, Newman L, Mansbach H, Jones M, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study.
Headache. 2004;44(9):856–864. (Guideline Ref ID TEPPER2004) [
PubMed: 15447694]
- 249.
Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine.
Lancet. 1995;346(8980):923–926. (Guideline Ref ID TFELTHANSEN1995) [
PubMed: 7564725]
- 250.
The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine.
Eur Neurol. 1992;32(3):177–184. (Guideline Ref ID OSAMCSC1992) [
PubMed: 1317294]
- 251.
Thomas R, Cook A, Main G, Taylor T, Galizia CE, Swingler R. Primary care access to computed tomography for chronic headache.
British Journal of General Practice. 2010;60(575):426–430. (Guideline Ref ID THOMAS2010) [
PMC free article: PMC2880741] [
PubMed: 20529496]
- 252.
Thompson M, Gawel M, Desjardins B, Ferko N, Grima D. An economic evaluation of rizatriptan in the treatment of migraine.
Pharmacoeconomics. 2005;23(8):837–850. (Guideline Ref ID THOMPSON2005) [
PubMed: 16097844]
- 253.
Torelli P, Beghi E, Manzoni GC. Validation of a questionnaire for the detection of cluster headache.
Headache. 2005;45(6):644–652. (Guideline Ref ID TORELLI2005) [
PubMed: 15953296]
- 254.
Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bes A. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
Neurology. 1996;47(2):361–365. (Guideline Ref ID TOUCHON1996) [
PubMed: 8757005]
- 255.
Tsushima Y, Endo K. MR imaging in the evaluation of chronic or recurrent headache.
Radiology. 2005;235(2):575–579. (Guideline Ref ID TSUSHIMA2005) [
PubMed: 15858096]
- 256.
Tuchin PJ, Pollard H, Bonello R. A randomized controlled trial of chiropractic spinal manipulative therapy for migraine.
Journal of Manipulative and Physiological Therapeutics. 2000;23(2):91–95. (Guideline Ref ID TUCHIN2000) [
PubMed: 10714533]
- 257.
Tuchman MM, Hee A, Emeribe U, Silberstein S. Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study.
CNS Drugs. 2008;22(10):877–886. (Guideline Ref ID TUCHMAN2008) [
PubMed: 18788838]
- 258.
Van De Ven LLM, Franke CL, Koehler PJ. Prophylactic treatment of migraine with bisoprolol: A placebo- controlled study.
Cephalalgia. 1997;17(5):596–599. (Guideline Ref ID VANDEVEN1997) [
PubMed: 9251876]
- 259.
van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, et al. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.
Neurology. 2003;60(4):630–633. (Guideline Ref ID VANVLIET2003) [
PubMed: 12601104]
- 260.
Varkey E, Cider A, Carlsson J, Linde M. Exercise as migraine prophylaxis: A randomized study using relaxation and topiramate as controls.
Cephalalgia. 2011;31(14):1428–1438. (Guideline Ref ID VARKEY2011) [
PMC free article: PMC3236524] [
PubMed: 21890526]
- 261.
Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N. Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis.
Health Technology Assessment. 2004;8(48):1–50. (Guideline Ref ID VICKERS2004) [
PubMed: 15527670]
- 262.
Victor S, Ryan SW. Drugs for preventing migraine headaches in children.
Cochrane Database of Systematic Reviews. 2008;(4):CD002761. (Guideline Ref ID VICTOR2008) [
PubMed: 14583952]
- 263.
Wang HZ, Simonson TM, Greco WR, Yuh WT. Brain MR imaging in the evaluation of chronic headache in patients without other neurologic symptoms.
Academic Radiology. 2001;8(5):405–408. (Guideline Ref ID WANG2001A) [
PubMed: 11345271]
- 264.
Weatherall MW. Acute neurology in a twenty-first century district general hospital. Journal of the Royal College of Physicians of Edinburgh. 2006;36(3):196–200. (Guideline Ref ID WEATHERALL2006)
- 265.
Weber-Schoendorfer C, Hannemann D, Meister R, Elefant E, Cuppers-Maarschalkerweerd B, Arnon J, et al. The safety of calcium channel blockers during pregnancy: A prospective, multicenter, observational study.
Reproductive Toxicology. 2008;26(1):24–30. (Guideline Ref ID WEBER2008) [
PubMed: 18585452]
- 266.
White A, Hayhoe S, Hart A, Ernst E. Survey of adverse events following acupuncture (SAFA): a prospective study of 32,000 consultations.
Acupuncture in Medicine. 2001;19(2):84–92. (Guideline Ref ID WHITE2001) [
PubMed: 11829164]
- 267.
Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many.
Journal of General Internal Medicine. 1997;12(7):439–445. (Guideline Ref ID WHOOLEY1997) [
PMC free article: PMC1497134] [
PubMed: 9229283]
- 268.
Williamson DA. Relaxation for the treatment of headache: Controlled evaluation of two group programs.
Behavior Modification. 1984;8(3):407–424. (Guideline Ref ID WILLIAMSON1984) [
PubMed: 6383339]
- 269.
Winner P, Ricalde O, Le FB, Saper J, Margul B. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
Archives of Neurology. 1996;53(2):180–184. (Guideline Ref ID WINNER1996) [
PubMed: 8639069]
- 270.
Witt CM, Pach D, Reinhold T, Wruck K, Brinkhaus B, Mank S, et al. Treatment of the adverse effects from acupuncture and their economic impact: a prospective study in 73,406 patients with low back or neck pain.
European Journal of Pain. 2011;15(2):193–197. (Guideline Ref ID WITT2011) [
PubMed: 20609604]
- 271.
Witt CM, Reinhold T, Jena S, Brinkhaus B, Willich SN. Cost-effectiveness of acupuncture treatment in patients with headache.
Cephalalgia. 2008;28(4):334–345. (Guideline Ref ID WITT2008) [
PubMed: 18315686]
- 272.
Yorkshire Wolds and Coast Primary Care Trust; Scarborough WaRPCT; Scarborough and North East Yorkshire Healthcare NHS Trust. (Guideline Ref ID SCARBOROUGH2005)
- 273.
Yu J, Smith KJ, Brixner DI. Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application.
CNS Drugs. 2010;24(8):695–712. (Guideline Ref ID YU2010) [
PubMed: 20658800]
- 274.
Yue NC, Longstreth WT Jr, Elster AD, Jungreis CA, O’Leary DH, Poirier VC. Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study.
Radiology. 1997;202(1):41–46. (Guideline Ref ID YUE1997) [
PubMed: 8988190]
- 275.
Zebenholzer K, Wober C, Kienbacher C, Wober-Bingol C. Migrainous disorder and headache of the tension-type not fulfilling the criteria: a follow-up study in children and adolescents.
Cephalalgia. 2000;20(7):611–616. (Guideline Ref ID ZEBENHOLZER2000) [
PubMed: 11128817]
- 276.
Zhang L, Hay JW. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
CNS Drugs. 2005;19(7):635–642. (Guideline Ref ID ZHANG2005) [
PubMed: 15984898]
